Kerry announces acquisition of Pevesa Biotech
Kerry, the Taste & Nutrition company, is expanding its non-allergenic and organic plant protein capability by acquiring the Spanish company Pevesa Biotech. The acquisition enhances Kerry’s leadership position in the hydrolysed plant protein space for specialised nutrition and expands the company’s capacity to serve the rapidly growing organic plant protein market.
Based in Spain, Pevesa Biotech is a well-established global leader in non-allergenic, non-GMO plant proteins for the infant, general and clinical nutrition markets.
“Kerry is extremely pleased to bring the global expertise of Pevesa into our leading plant protein portfolio,” said John Reilly, vice president of Business Development Proteins at Kerry.
“Kerry was attracted to Pevesa because of its expertise, innovation, high-quality manufacturing leadership, and patented technology in the non-allergenic plant protein market. This will be a good fit with Kerry’s growing plant protein product portfolio, and Pevesa’s customers will benefit from the synergy between its market-leading technology and Kerry’s protein processing expertise.”
